REDMILE
San Francisco
Also known as Redmile Group, Llc
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathAbcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.
BiotechHealthtechNewton, US
John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Ryan Berry(Director)Donald McCarthy(Director)John Edwards(Director)Yajun Xu(Director)
Bambusa Therapeutics develops bispecific antibodies for immunological and inflammatory (I&I) disorders, using antibody engineering to target multiple I&I indications.
BiotechHealthtechMedical DevicesAustin, US
Shanshan Xu(Founder & Chief Executive Officer)Helmut Jeggle(Co-Founder)Thang Ho(Chief Development Officer)Crystal MacKay(Chief Operating Officer)
Fund performance · per public LP disclosures · 2
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Redmile Biopharma Investments III, L.P.LPs: Teachers' Retirement System of Oklahoma | 2021 | — | — | 0.99x | 0.17x |
| Redmile Capital Fund, LPLPs: Texas Municipal Retirement System | — | — | — | 0.96x | 0.91x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- Where is REDMILE located?
- REDMILE is headquartered in San Francisco.